This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September 2026 quarter revenue up 15%, profit after tax up 59% year on year
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On a consolidated basis for the quarter ended 30 September 2026, revenue from operations was Rs 636.19 crore versus Rs 553.72 crore a year earlier; profit after tax was Rs 14.56 crore versus Rs 9.17 crore. EBITDA margin rose to 12.8% from 8.6%. Six-month consolidated operating cash flow was negative Rs 42.87 crore. The review conclusion was unmodified. A promoter-group firm bought a group subsidiary for Rs 0.46 crore.
Consolidated profit rose, but standalone profit fell and negative cash flow may weigh on sentiment; the promoter-group sale may draw scrutiny.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹636.2 Cr | ₹553.9 Cr | +14.9% |
| Operating profit | ₹23.78 Cr | ₹11.38 Cr | +109.0% |
| Profit after tax | ₹14.56 Cr | ₹9.17 Cr | +58.8% |
| EBITDA margin | 12.4% | 9.6% | +2.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.